*BAYER-15786

Study Sponsor: Bayer

Study Title

A randomized controlled trial of rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery disease (COMPASS - Cardiovascular OutcoMes for People using Anticoagulation StrategieS).

Medicine or Vaccine (generic name)

Rivaroxaban

Sponsor Identification Number

15786

Trial Registry Identification Number(#'s)

NCT01776424

Medical Condition

MACE prevention

Phase

Phase 3

Link to study details on the Bayer Clinical Study Register

https://clinicaltrials.bayer.com/study/1913

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT01776424?term=NCT01776424&rank=1

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

Since study is still ongoing, data provided will be on basis of datasets provided to authorities for obtaining market approval.

Date Added to this Site

April 2019